• What is it:
    • Subpleural nodules in the lungs refer to:
      • the presence of:
        • multiple or solitary nodules,
        • located immediately adjacent to the pleura,
        • including the fissures.
    • These nodules are commonly associated with:
      • inflammatory,
      • infectious,
      • neoplastic, or
      • lymphatic processes.
  • Etymology:
    • Derived from the Latin sub- (under or beneath) and pleura (side or rib), describing nodules beneath the pleural surface.
  • AKA:
    • Pleural-adjacent nodules.
  • How does it appear on each relevant imaging modality:
    • Chest X-ray:
      • Subtle or indistinct opacities near the pleura.
      • Better visualized with lateral or oblique views if nodules are small.
    • Chest CT:
      • Parts: Nodules located immediately adjacent to the pleural surfaces, including interlobar fissures.
      • Size: Varies from micronodules (<3 mm) to larger nodules (>10 mm).
      • Shape: Round or oval; may appear irregular depending on the cause.
      • Position:
        • Adjacent to pleural surfaces or fissures, predominantly peripheral in location.
      • Character:
        • May appear solid, calcified, or associated with ground-glass opacity.
        • Cavitation is less common  but may occur in certain conditions (e.g., septic emboli infection or malignancy).
      • Time:
        • Subpleural nodules may evolve, resolve (e.g., infections), or grow (e.g., malignant or progressive inflammation).
    • MRI:
      • Rarely used but may demonstrate hyperintensity on T2-weighted images if inflammation or edema is present.
    • PET-CT:
      • Recommended for lesions larger than 7 mm.
      • Identifies:
        • Active lesions with increased metabolic activity (e.g., malignant or acute inflammation/infection).
        • Cold lesions with low metabolic activity (e.g., chronic inflammation or paucicellular neoplasms).
  • These nodules reflect:
    • Pleural-adjacent pathology:
      • Inflammation:
        • Hypersensitivity pneumonitis.
        • Rheumatoid nodules.
      • Infection:
        • Tuberculosis with subpleural involvement.
        • Fungal infections (e.g., aspergillosis, histoplasmosis).
      • Lymphatic involvement:
        • Sarcoidosis (perilymphatic distribution).
        • Lymphangitic carcinomatosis.
      • Neoplastic processes:
        • Subpleural metastases.
  • Differential diagnosis:
    • Infection:
      • Tuberculosis (primary or post-primary with subpleural focus).
      • Fungal infections (e.g., coccidioidomycosis, histoplasmosis).
    • Inflammation:
      • Sarcoidosis (early or chronic stages).
      • Hypersensitivity pneumonitis (subpleural micronodules).
    • Neoplasm:
      • Subpleural metastases (e.g., breast cancer, melanoma).
      • Pleural-based primary tumors (e.g., mesothelioma).
    • Inhalational exposure:
      • Pneumoconioses (e.g., silicosis, asbestosis with subpleural fibrosis).
    • Immune-related:
      • Rheumatoid nodules.
    • Iatrogenic:
      • Post-radiotherapy nodules.
    • Circulatory:
      • Pulmonary infarcts adjacent to the pleura.
  • Recommendations:
    • Perform high-resolution CT to define the size, position, and morphology of subpleural nodules.
    • Bronchoscopy or biopsy if malignancy or granulomatous diseases are suspected.
    • PET-CT to differentiate between active and cold lesions for nodules larger than 7 mm.
    • Monitor with follow-up imaging for changes in size or character over time.
  • Key points and pearls:
    • Subpleural nodules are often associated with pleural or lymphatic processes.
    • Nodules along fissures may suggest perilymphatic spread (e.g., sarcoidosis or metastases).
    • Calcified nodules are typically benign (e.g., healed granulomas).
    • Subpleural positioning and time-dependent changes (e.g., growth, resolution) are critical for diagnosis and management.